Fabrinet: Shorts Pile In as MSCI Exit and Analyst Cuts Converge

Three distinct forces are pulling on FN at once. Short interest just jumped 13.3% in a single day. Analysts are cutting targets aggressively. And ORTEX forecasts the stock is almost certain to be dropped from several major MSCI indices next month.

Shorts Accelerate Into the Slide

Short interest in Fabrinet rose to 5.21% of the free float as of 26 October, up from 4.60% a week earlier and up 32% over the past month. That is the highest level since mid-September, and the one-day jump of 13.3% stands out against a backdrop where the stock is already down 22% over the past month.

The borrow market remains extremely loose. Availability sits at 7,431%, meaning shares to borrow are plentiful. Cost to borrow is 0.28%, near its lowest in months. Short sellers face no friction adding positions here.

Analysts Keep Cutting

This morning Needham's Ryan Koontz cut his price target from $650 to $500 while keeping a Buy rating. That follows Susquehanna's Christopher Rolland trimming from $850 to $600 last week, and B. Riley Securities lowering from $598 to $431 the week before. The consensus target still sits at $688, more than 110% above the current price of $325. That gap reflects how fast the stock has moved, not confidence in a near-term recovery.

Earnings are due 2 November, six days away. The prior print, in August, sent the stock down 15.4% on the day and 26.1% over the following five sessions.

The MSCI Rebalance Adds Mechanical Pressure

ORTEX forecasts a 97% probability that Fabrinet is dropped from the MSCI USA, MSCI World, MSCI Kokusai and MSCI North America indices at the November 2026 Quarterly Review. The announcement is expected 11 November, with the trade date on 30 November.

The implied selling flow is $465M to $697M depending on the index, equivalent to 1.6 to 2.3 days of normal trading volume. Simultaneously, ORTEX puts a 96% probability on additions to MSCI USA Small and MSCI World Small, which would generate buying flows of $465M and $232M respectively. The net effect depends on the relative size of passive mandates tracking each index, but the large-cap deletion flows are the bigger number.

The price that determines the deletion outcome for the large-cap indices is $374.78. FN is currently 15.2% below that level.

Options Skew and Retail Attention

The put/call ratio has fallen to 0.66, now 1.75 standard deviations below its 20-day mean of 0.73. The pattern described in the prior note from 21 October holds: call-skewed positioning alongside a falling stock is more consistent with expiring hedges and short-dated call writing than genuine conviction buying.

Retail attention, measured as the combined z-score of English Wikipedia article views and ORTEX stock-page traffic, hit 2.7 standard deviations above its 90-day average as of 22 October. That is elevated engagement, though this dataset has not been shown to lead the company's reported figures.

Data Summary

• Short interest: 5.21% of free float, up 13.3% in one day, up 32% month-on-month
• Availability: 7,431%, borrow remains loose; cost to borrow 0.28%
• Stock: $325.24, down 22% over the past month, down 10.3% over the past week
• Consensus price target: $688; three target cuts in the past two weeks
• ORTEX index forecast: 97% probability of deletion from MSCI USA and related large-cap indices; announcement expected 11 November, trade date 30 November
• Earnings: 2 November; prior print triggered a 15.4% one-day decline
• The price that flips the MSCI deletion call: $374.78